Navigation Links
Pharmaceutical Contract Manufacturing and API Sourcing in Central Europe and the Balkan States 2011
Date:8/16/2011

NEW YORK, Aug. 16, 2011 /PRNewswire/ --Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011

http://www.reportlinker.com/p0592261/Pharmaceutical-contract-manufacturing-and-API-sourcing-in-Central-Europe and-the-Balkan-states-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Legal_Services

Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011 is the latest report providing an in-depth analysis for pharmaceutical contract manufacturing and API sourcing in six Central European countries: the Czech Republic, Slovakia, Hungary, Poland, Romania and Bulgaria and three Balkan states: Croatia, Serbia and Slovenia. The report examines current and future trends in contract manufacturing in the whole of the region and describes key drivers and barriers for contract manufacturing in each country. 

With the growing market trends for pharmaceutical outsourcing, the region of Central Europe and the Balkans is becoming increasingly competitive to China and India. As a result many companies in the region offer attractive product and service offerings for contract manufacturing and API sourcing, based on their experience in the market, their specialized area of operations and developed product and service portfolio.  The report draws on comparisons with other regions, including the Far East and others. 

The report identifies the most attractive companies in the region, providing detailed company profiles, financial data and production capacity for each company, alongside an easy to use map with manufacturer locations in the region.  Each country is examined in terms of its strengths and weaknesses and their attractiveness for contract manufacturing and API sourcing in the region.  

Key Highlights:

        Market analysis for 2011, current and future trends, key drivers and barriers, market data

        Country specific evaluation of competitiveness and attractiveness for contract manufacturing and API sourcing in the region

        Regional benchmark analysis: Central Europe versus Far East

        Opportunities for company contract manufacturing and sourcing in the region

        Detailed profiles of companies offering contract manufacturing

        Manufacturer location map

Table of contents: 

Report methodology 15 

Executive summary 19 

General overview of contract manufacturing and 

API sourcing in CE and the Balkan states 27 

Key recent trends and events on the contract 

manufacturing and API sourcing markets in CE and the 

Balkan states 27 

Comparison of CE and Balkan region with other 

competitive regions 31 

Possibility of contract manufacturing and API sourcing 

in specific CE and Balkan countries 36 

Czech Republic 37 

Main characteristics of, and current trends in, 

API manufacturing and manufacturing 

under contract 37 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 40 

Profiles of key companies offering contract 

manufacturing services and API 43 

Poland 79 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 79 

Key drivers of, and obstacles to, contract manufacturing 

and API sourcing 81 

Profiles of key companies offering contract 

manufacturing services and API 83 

Hungary 133 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 133 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 134 

Profiles of key companies offering contract 

manufacturing services and API 136 

Romania 155 

Main characteristics of, and current trends in, 

API manufacturing and manufacturing under 

contract 155 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 156 

Profiles of key companies offering contract 

manufacturing services and API 158 

Bulgaria 181 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 181 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 182 

Profiles of key companies offering contract 

manufacturing services and API 184 

Slovakia 193 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 193 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 194 

Profiles of key companies offering contract 

manufacturing services and API 196 

Slovenia 209 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 209 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 209 

Profiles of key companies offering contract 

manufacturing services and API 211 

Croatia 215 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 215 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 216 

Profiles of key companies offering contract 

manufacturing services and API 217 

Serbia 223 

Main characteristics of, and current trends in, API 

manufacturing and manufacturing under contract 223 

Key drivers of, and obstacles, to contract manufacturing 

and API sourcing 224 

Profiles of key companies offering contract 

manufacturing services and API 226 

Profiles of companies present in more than one CE 

or Balkan country 235 

Legal environment 241 

GMP rules 241 

REACH Regulation 243 

Changes anticipated in EU legislation – draft Directive 

2001/83/EC 244 

Business climate in CE and Balkans 245 

Individual competitive advantages of CE 

and Balkan countries 245 

Degree of sophistication of the production process 

in the CE and Balkan countries 246 

Import and export indicators 246 

Key macroeconomic and demographic indicators 

in CE and Balkan countries 253 

GDP growth 253 

Inflation rates 256 

Labour market 257 

List of graphs 259 

List of tables 261

About PMR 263

To order this report:

Legal Services Industry: Pharmaceutical contract manufacturing and API sourcing in Central Europe and the Balkan states 2011

Legal Services Business News

More  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... , May 30, 2016 ... titled, "Advanced (3D/4D) Visualization Systems Market - Global Industry ... 2024." According to the report, the global advanced (3D/4D) ... in 2015 and is anticipated to expand at a ... US$ 3.2 Bn in 2024. Advanced (3D/4D) ...
(Date:5/30/2016)... -- - DCGI grants limited approval to market Stempeucel® ... - Stempeucel® becomes 5th off-the-shelf Stem cell product to be ... - Buerger,s Disease (also known as Thromboangiitis Obliterans) is a major ... - Prevalence of Buerger,s Disease is estimated to be ... persons in the European Community & USA ...
(Date:5/27/2016)... PUNE, India , May 27, 2016 ... in the instances of hypertension is driving ambulatory blood ... muscles lose their elasticity and their ability to respond ... blood pressure. This condition can lead to various cardiovascular ... and peripheral vascular disease. These diseases are growing in ...
Breaking Medicine Technology:
(Date:5/31/2016)... , ... May 31, 2016 , ... Phynd Technologies, Inc. ... GA; Houston Methodist – Houston, TX and Shore Medical Center – Somers Point, NJ. ... three different, leading EHR solutions, demonstrating the breadth of Phynd’s solution and its interoperability. ...
(Date:5/31/2016)... ... , ... In a recent interview on The Greenburgh Report radio show hosted ... WVOX (1460 AM), leading medical insurance advocate Adria Goldman Gross discussed several eye-opening ... maelstrom.” , During the interview with Mr. Feiner that aired on May 7, ...
(Date:5/31/2016)... ... ... Dr. Charles A. Ditta attained his Doctor of Medical Dentistry Degree from ... where he graduated in the top ten percentile of his class. Dr. Ditta has ... has been a member in good standing for thirty years in the American Dental ...
(Date:5/31/2016)... ... May 31, 2016 , ... To meet ... to the healthcare industry, The University of Scranton is adding a Certificate in ... to a career in rapidly growing field of healthcare information. , Healthcare ...
(Date:5/31/2016)... ... May 31, 2016 , ... Super Powder, a supplement produced ... the go individuals and dedicated athletes, continues to transform the nutritional supplement industry by ... pea and milk protein, branched-chain amino acids (BCAA), alkaline minerals, wheat grass, digestive enzymes, ...
Breaking Medicine News(10 mins):